Histone modification profiling in breast cancer cell lines highlights commonalities and differences among subtypes

Area of Science:

• Oncology
• Epigenetics
• Genomics

Background:

• Epigenetic regulators are frequently altered in cancers, impacting cell identity and treatment response.
• Aberrant epigenetic modifications drive transcriptional changes in various malignancies.

Purpose of the Study:

• To define epigenetic landscape alterations in breast cancer subtypes.
• To identify subtype-specific chromatin signatures and potential biomarkers.

Main Methods:

• ChIP-Seq for 8 histone modifications.
• GRO-seq and RNA-Seq for transcriptome profiling.
• Analysis across 13 breast cancer cell lines representing 5 molecular subtypes.

Main Results:

• Defined subtype-specific chromatin signatures using combinatorial histone modification patterns.
• Identified AFAP1-AS1 as a triple-negative breast cancer-specific gene linked to proliferation and epithelial-mesenchymal-transition.
• Observed decreased androgen receptor pathway activity and increased vitamin D biosynthesis pathway activity in basal TNBC cell lines.

Conclusions:

• Comprehensive resource of histone modification profiles for breast cancer subtypes.
• Revealed key chromatin signatures with potential for novel therapeutic target identification.
• Highlights AFAP1-AS1 as a promising biomarker for triple-negative breast cancer.